Author
Carles Cantó
- Indexed works
- 16
- Total citations
- 4,408
- Active years
- 11
Collaborators
Works in the record
Cell 2013
Open access · OA
The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling
Endocrine Reviews 2010
Open access · OA
The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways
Scientific Reports 2011
Open access · CC-BY
The metabolic footprint of aging in mice
Nature Communications 2016
Open access · CC-BY
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Hepatology 2015
Open access · CC-BY
Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice
Scientific Reports 2011
Open access · CC-BY
SRT1720 improves survival and healthspan of obese mice
Molecular Metabolism 2019
Open access · CC-BY
A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor
Nature Metabolism 2024
Open access · CC-BY
Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia
Cold Spring Harbor Symposia on Quantitative Biology 2011
Preprint · OA
NAD+ as a Signaling Molecule Modulating Metabolism
Cell Reports 2017
Open access · OA
Circadian and Feeding Rhythms Orchestrate the Diurnal Liver Acetylome
The FASEB Journal 2021
Open access · OA
Reduced nicotinamide mononucleotide is a new and potent NAD <sup>+</sup> precursor in mammalian cells and mice
Nature Communications 2019
Open access · CC-BY
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage
Cellular and Molecular Life Sciences 2022
Open access · CC-BY
Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
International Journal of Molecular Sciences 2021
Open access · CC-BY
A Method to Monitor the NAD+ Metabolome—From Mechanistic to Clinical Applications
Nature Aging 2025
Preprint · OA
Emerging strategies, applications and challenges of targeting NAD+ in the clinic
Frontiers in Cell and Developmental Biology 2022
Open access · CC-BY